Reducing Hereditary Cancer Act

# Reducing Hereditary Cancer Act Summary **What the Bill Would Do** This bill would expand Medicare coverage to include genetic testing for hereditary cancer mutations. If passed, it would allow Medicare to pay for tests that identify whether someone has inherited genes that significantly increase their cancer risk (such as BRCA1/BRCA2). The bill would also cover preventive surgeries and enhanced screening procedures for Medicare beneficiaries who test positive for these mutations. **Who It Affects and Key Provisions** The bill primarily affects Medicare recipients who have a personal or family history of hereditary cancer or suspect they may carry cancer-related genetic mutations.

By covering genetic testing upfront, the legislation aims to identify at-risk individuals early so they can pursue preventive measures. The coverage would extend beyond just the genetic test itself to include follow-up risk-reducing surgeries and intensive screening programs—potentially helping people avoid cancer development or catch it at earlier, more treatable stages. **Current Status** As of now, the bill is in committee and has not advanced further in the legislative process. Sponsored by Representative Debbie Wasserman Schultz (D-FL), it remains under review and would require committee approval and a full House vote before proceeding.